Patanjali's research on herbo-mineral medicine, Melanogrit, has found place in the noted journal Bioscience Reports. This international research journal falls under the aegis of Biochemical Society, UK, an institution with over a century of establishment that actively contributes to the advancement of biological sciences and plays pivotal roles in advocating for government policies and supporting academic systems.

Acharya Balkrishna of Patanjali Yogpeeth said that the achievement is a significant milestone highlighting the intensive research conducted by scientists at the Patanjali Research Foundation on skin white patches, leveraging the principles of Ayurveda. In this hallmark study, the therapeutic potentials of the herbo-mineral medicine Melanogrit were determined to potentiate the melanin production in B16F10 cells (melanocytes) that are responsible for the process of melanogenesis.

Emphasising the scientific perspective of the study Balkrishna stated that Melanogrit effectively enhanced the expression of crucial melanogenesis pathway genes leading to an observable rise in cellular tyrosine activity. Patanjali has been treating thousands of patients suffering from vitiligo and leucoderma for years, and now, its cellular validation has been acknowledged scientifically by the UK and the entire world, he said.

Previously deemed rather incurable, these diseases are now effectively addressed and resolved at Patanjali. The recognition of this research symbolises the success of India, Balkrishna added.